---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014318"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:44:10.698037+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ernexa completes second closing of $6M private placement; total $7M raised; expects to regain Nasdaq compliance

## Summary
- Second closing on June 9, 2025: issued 47.7M shares and 9.3M pre-funded warrants for ~$6.0M gross proceeds.
- Combined with April 2 closing, total 57.7M shares and 9.8M warrants issued for ~$7.0M.
- Proceeds to be used for working capital and repaying certain notes.
- Company believes it now satisfies Nasdaq Stockholders' Equity Standard ($2.5M minimum) as alternative to Market Value Standard.
- Pre-funded warrants exercisable at $0.005 per share with 4.99%/9.99% beneficial ownership limitation.

## SEC filing metadata
- accession: 0001641172-25-014318
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000164117225014318/0001641172-25-014318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000164117225014318/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014318
- JSON: https://secwatch.observer/filing/0001641172-25-014318.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014318.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.